The Downstream Processing Market is poised for significant growth, projected to rise from USD 12.5 billion in 2024 to USD 20.3 billion by 2033, with a compound annual growth rate (CAGR) of 6.8%. Key drivers include increased biopharmaceutical production, the demand for monoclonal antibodies, and advancements in cell and gene therapies. Innovations in purification technologies, including continuous bioprocessing and single-use systems, are enhancing cost efficiency and operational flexibility. Major growth areas include personalized medicine and biosimilars. North America leads the market, while Asia-Pacific is the fastest-growing region due to expanding biopharma manufacturing capabilities. The report also highlights the challenges of high capital expenditure and regulatory complexities, which may inhibit market entry for smaller players.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.prnewswire.co.uk/news-releases/downstream-processing-market-trends-size-surges-to-usd-20-3-billion-by-2033–propelled-by-6-8-cagr—verified-market-reports-302743235.html
